Glibenclamide therapy: pros and cons

The safety of antidiabetic medications has received much attention in the resent past. Although concerns on the safety of glibenclamide therapy iscontroversial, some studies showed an increased risk of cardiovascular morbidity (f.e. myocardial infarction) and risk of mortality in subjects usingglibe...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Olga Konstantinovna Vikulova, Marina Vladimirovna Shestakova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2011
Materias:	diabetes mellitus type 2 glibenclamide hypoglysemia mortality Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/176cc5d7a32949878807dfda4fd62a37
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:176cc5d7a32949878807dfda4fd62a37
record_format	dspace
spelling	oai:doaj.org-article:176cc5d7a32949878807dfda4fd62a372021-11-14T09:00:16ZGlibenclamide therapy: pros and cons2072-03512072-037810.14341/2072-0351-6231https://doaj.org/article/176cc5d7a32949878807dfda4fd62a372011-09-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/6231https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378The safety of antidiabetic medications has received much attention in the resent past. Although concerns on the safety of glibenclamide therapy iscontroversial, some studies showed an increased risk of cardiovascular morbidity (f.e. myocardial infarction) and risk of mortality in subjects usingglibenclamide, but not other SU (gliclazide or glimepiride)Olga Konstantinovna VikulovaMarina Vladimirovna ShestakovaEndocrinology Research Centrearticlediabetes mellitus type 2glibenclamidehypoglysemiamortalityNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 14, Iss 3, Pp 92-96 (2011)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	diabetes mellitus type 2 glibenclamide hypoglysemia mortality Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	diabetes mellitus type 2 glibenclamide hypoglysemia mortality Nutritional diseases. Deficiency diseases RC620-627 Olga Konstantinovna Vikulova Marina Vladimirovna Shestakova Glibenclamide therapy: pros and cons
description	The safety of antidiabetic medications has received much attention in the resent past. Although concerns on the safety of glibenclamide therapy iscontroversial, some studies showed an increased risk of cardiovascular morbidity (f.e. myocardial infarction) and risk of mortality in subjects usingglibenclamide, but not other SU (gliclazide or glimepiride)
format	article
author	Olga Konstantinovna Vikulova Marina Vladimirovna Shestakova
author_facet	Olga Konstantinovna Vikulova Marina Vladimirovna Shestakova
author_sort	Olga Konstantinovna Vikulova
title	Glibenclamide therapy: pros and cons
title_short	Glibenclamide therapy: pros and cons
title_full	Glibenclamide therapy: pros and cons
title_fullStr	Glibenclamide therapy: pros and cons
title_full_unstemmed	Glibenclamide therapy: pros and cons
title_sort	glibenclamide therapy: pros and cons
publisher	Endocrinology Research Centre
publishDate	2011
url	https://doaj.org/article/176cc5d7a32949878807dfda4fd62a37
work_keys_str_mv	AT olgakonstantinovnavikulova glibenclamidetherapyprosandcons AT marinavladimirovnashestakova glibenclamidetherapyprosandcons
_version_	1718429572579459072

Glibenclamide therapy: pros and cons

Ejemplares similares